Relationship between the structure of analogues of amsacrine and their degree of cross-resistance to adriamycin-resistant P388 leukaemia cells
- 1 February 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (2) , 205-210
- https://doi.org/10.1016/0277-5379(88)90254-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of AmsacrineEuropean Journal of Cancer and Clinical Oncology, 1987
- Increase in Nonspecific Adsorptive Endocytosis in Anthracycline-and Vinca Alkaloid-Resistant Ehrlich Ascites Tumor Cell Lines2JNCI Journal of the National Cancer Institute, 1987
- Verapamil modulates mutagenicity of antitumour acridines in bacteria and yeastBiochemical Pharmacology, 1986
- Human Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene AmplificationScience, 1986
- The use of human cancer cell lines as a primary screening system for antineoplastic compoundsEuropean Journal of Cancer and Clinical Oncology, 1984
- Differential growth inhibition of cultured mammalian cells: Comparison of clinical antitumour agents and amsacrine derivativesEuropean Journal of Cancer and Clinical Oncology, 1984
- Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in miceEuropean Journal of Cancer and Clinical Oncology, 1983
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983
- Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycinBiochemistry, 1981
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesPublished by Elsevier ,1974